Quantum Cyber NV (QUCY)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Oct 02, 16:00
1.31
-0.02
(-1.50%)
After-Hours: 20:00
Quantum Cyber Enterprise Value : 28.87M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 28.87M |
| October 01, 2026 | 29.37M |
| September 30, 2026 | 28.37M |
| September 29, 2026 | 27.87M |
| September 28, 2026 | 29.62M |
| September 25, 2026 | 29.87M |
| September 24, 2026 | 28.87M |
| September 23, 2026 | 28.62M |
| September 22, 2026 | 28.62M |
| September 21, 2026 | 28.12M |
| September 18, 2026 | 30.11M |
| September 17, 2026 | 29.62M |
| September 16, 2026 | 28.37M |
| September 15, 2026 | 28.37M |
| September 14, 2026 | 28.62M |
| September 11, 2026 | 29.12M |
| September 10, 2026 | 29.87M |
| September 09, 2026 | 30.36M |
| September 08, 2026 | 31.11M |
| September 04, 2026 | 35.35M |
| September 03, 2026 | 33.60M |
| September 02, 2026 | 35.60M |
| September 01, 2026 | 32.61M |
| August 31, 2026 | 34.85M |
| August 28, 2026 | 31.11M |
| Date | Value |
|---|---|
| August 27, 2026 | 32.36M |
| August 26, 2026 | 29.99M |
| August 25, 2026 | 29.62M |
| August 24, 2026 | 28.37M |
| August 21, 2026 | 28.12M |
| August 20, 2026 | 29.62M |
| August 19, 2026 | 31.61M |
| August 18, 2026 | 31.36M |
| August 17, 2026 | 32.36M |
| August 14, 2026 | 32.48M |
| August 13, 2026 | 31.11M |
| August 12, 2026 | 28.24M |
| August 11, 2026 | 29.87M |
| August 10, 2026 | 30.36M |
| August 07, 2026 | 31.61M |
| August 06, 2026 | 30.11M |
| August 05, 2026 | 31.86M |
| August 04, 2026 | 33.11M |
| August 03, 2026 | 27.12M |
| July 31, 2026 | 24.13M |
| July 30, 2026 | 23.38M |
| July 29, 2026 | 22.14M |
| July 28, 2026 | 22.89M |
| July 27, 2026 | 23.13M |
| July 24, 2026 | 22.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Veracyte, Inc. | 3.236B |
| bioAffinity Technologies, Inc. | 1.743M |
| ACADIA Pharmaceuticals, Inc. | 2.551B |
| Agenus, Inc. | 620.93M |
| Alnylam Pharmaceuticals, Inc. | 29.06B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.486M |
| Total Expenses (Quarterly) | 2.486M |
| EPS Diluted (Quarterly) | -0.4307 |
| Earnings Yield | -281.1% |
| Normalized Earnings Yield | -281.43 |